Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-970"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-970"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-9692
lpv:speaker	lp:Alain Cadec2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 member; Delegation for relations with South Africa (2009-09-16--2014-06-30)3 substitute; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 vice-chair; PECH (2009-10-07--2012-01-18)3 unknown; Union pour un Mouvement Populaire (2009-07-14--2014-06-30)3 member; REGI (2009-07-16--2012-01-18)3
lpv:translated text	"In the area of health, access to comprehensive, good quality information guarantees better results, insofar as patients are more likely to follow a treatment that they are able to understand. I join with the rapporteur in emphasising the difficulty in accessing this kind of information in some European countries, due to different interpretations by the Member States of the directive on information relating to medicinal products, as well as the unreliable and unclear nature of that information. We need to make it more accessible, in accordance with patients’ right to information. Nonetheless, in order to avoid creating any imbalance between Member States, it is vital to identify the means by which to disseminate this information, and not favour one at the expense of the others. Finally, it is essential to clearly distinguish between information and advertising and to prevent pharmaceutical companies from exploiting these information campaigns in order to promote their products."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph